131 related articles for article (PubMed ID: 7272955)
1. Hypercalcemia with ovarian carcinoma: evidence of a pathogenetic role for prostaglandins.
Josse RG; Wilson DR; Heersche JN; Mills JR; Murray TM
Cancer; 1981 Sep; 48(5):1233-41. PubMed ID: 7272955
[TBL] [Abstract][Full Text] [Related]
2. [A case of hypercalcemia with ovarian carcinoma].
Miura M; Hashiramoto M; Matsuda K; Nakano O; Suzuki K; Maeda M; Okada K; Chinzei T; Yamashiro K; Harui M
Gan No Rinsho; 1988 Dec; 34(15):2119-24. PubMed ID: 3230642
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit.
Voelkel EF; Tashjian AH; Franklin R; Wasserman E; Levine L
Metabolism; 1975 Aug; 24(8):973-86. PubMed ID: 1143092
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.
Tashjian AH; Voelkel EF; Levine L; Goldhaber P
J Exp Med; 1972 Dec; 136(6):1329-43. PubMed ID: 4345106
[TBL] [Abstract][Full Text] [Related]
5. Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors.
Minkin C; Fredericks RS; Pokress S; Rude RK; Sharp CF; Tong M; Singer FR
J Clin Endocrinol Metab; 1981 Nov; 53(5):941-7. PubMed ID: 6793615
[TBL] [Abstract][Full Text] [Related]
6. Humoral hypercalcemia of malignancy. Release of a prostaglandin-stimulating bone-resorbing factor in vitro by human transitional-cell carcinoma cells.
Bringhurst FR; Bierer BE; Godeau F; Neyhard N; Varner V; Segre GV
J Clin Invest; 1986 Feb; 77(2):456-64. PubMed ID: 3003159
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic hypercalcaemia in ovarian carcinoma.
Allan SG; Lockhart SP; Leonard RC; Smyth JF
Br Med J (Clin Res Ed); 1984 Jun; 288(6432):1714-5. PubMed ID: 6428510
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.
Seyberth HW; Segre GV; Morgan JL; Sweetman BJ; Potts JT; Oates JA
N Engl J Med; 1975 Dec; 293(25):1278-83. PubMed ID: 1186822
[TBL] [Abstract][Full Text] [Related]
9. Hypercalcemia in chronic myelogenous leukemia: evidence for excessive parathyroid hormone secretion.
Molho P; Grange MJ; Guéris J; Ballet JJ; Wautier JL; Tobelem G; Caen JP
Nouv Rev Fr Hematol (1978); 1985; 27(3):189-92. PubMed ID: 3862073
[TBL] [Abstract][Full Text] [Related]
10. Canine ovarian serous papillary adenocarcinoma with neoplastic hypercalcemia.
Hori Y; Uechi M; Kanakubo K; Sano T; Oyamada T
J Vet Med Sci; 2006 Sep; 68(9):979-82. PubMed ID: 17019069
[TBL] [Abstract][Full Text] [Related]
11. Adult T-cell leukemia complicated by hypercalcemia. Report of three autopsy cases with special reference to the etiologic factor of hypercalcemia.
Haratake J; Ishii N; Horie A; Matsumoto M; Oda S; Satoh K
Acta Pathol Jpn; 1985 Mar; 35(2):437-48. PubMed ID: 3875211
[TBL] [Abstract][Full Text] [Related]
12. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption.
Yates AJ; Boyce BF; Favarato G; Aufdemorte TB; Marcelli C; Kester MB; Walker R; Langton BC; Bonewald LF; Mundy GR
J Bone Miner Res; 1992 Jul; 7(7):847-53. PubMed ID: 1642153
[TBL] [Abstract][Full Text] [Related]
13. Ovarian non-small cell neuroendocrine carcinoma with paraneoplastic parathyroid hormone-related hypercalcemia.
Ohira S; Itoh K; Shiozawa T; Horiuchi A; Ono K; Takeuchi H; Hosoda W; Konishi I
Int J Gynecol Pathol; 2004 Oct; 23(4):393-7. PubMed ID: 15381910
[TBL] [Abstract][Full Text] [Related]
14. The development of hypercalcemia in a patient with an ovarian tumor producing parathyroid hormone-related protein.
Fujino T; Watanabe T; Yamaguchi K; Nagasaki K; Onishi E; Iwamoto I; Dozono H; Nagata Y
Cancer; 1992 Dec; 70(12):2845-50. PubMed ID: 1451066
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome.
Seyberth HW
Klin Wochenschr; 1978 Apr; 56(8):373-87. PubMed ID: 205705
[TBL] [Abstract][Full Text] [Related]
16. Congenital mesoblastic nephroma with hypercalcemia. Pathogenetic role of prostaglandins.
Vido L; Carli M; Rizzoni G; Calò L; Dalla Palma P; Parenti A; Fusco F
Am J Pediatr Hematol Oncol; 1986; 8(2):149-52. PubMed ID: 3017143
[TBL] [Abstract][Full Text] [Related]
17. Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma.
Robertson RP; Baylink DJ; Marini BJ; Adkison HW
J Clin Endocrinol Metab; 1975 Jul; 41(1):164-7. PubMed ID: 1150858
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma.
Tashjian AH; Voelkel EF; Goldhaber P; Levine L
Prostaglandins; 1973 Apr; 3(4):515-24. PubMed ID: 4729590
[No Abstract] [Full Text] [Related]
19. Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture.
Atkins D; Ibbotson KJ; Hillier K; Hunt NH; Hammonds JC; Martin TJ
Br J Cancer; 1977 Nov; 36(5):601-7. PubMed ID: 201261
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia in dogs with adenocarcinoma derived from apocrine glands of the anal sac. Biochemical and histomorphometric investigations.
Meuten DJ; Segre GV; Capen CC; Kociba GJ; Voelkel EF; Levine L; Tashjian AH; Chew DJ; Nagode LA
Lab Invest; 1983 Apr; 48(4):428-35. PubMed ID: 6300551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
